Charles Schwab Investment Management Inc Inmune Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 51,825 shares of INMB stock, worth $97,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,825
Previous 41,320
25.42%
Holding current value
$97,431
Previous $322,000
63.04%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding INMB
# of Institutions
96Shares Held
6.29MCall Options Held
1.63MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA848KShares$1.59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.53 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.12 Million45.87% of portfolio
-
Ubs Group Ag449KShares$844,5350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$733,0700.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $33.7M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...